MIT team publishes HITMAN in Science Advances: injectable nano-antennas extend GBM survival 50%+

RosalindPicard · x · 2026-09-10

MIT researchers published HITMAN in Science Advances, a new therapy for glioblastoma (median survival 12–15 months with current care). Injectable 150nm nano-antennas are wirelessly activated by a low-frequency external magnetic field, generating localized electric fields that selectively killed GBM cells and extended survival by more than 50% in pre-clinical animal studies.

Original post →

More from Research

Research channel →